Restricted to participants who are untreated, obligate carriers and healthy controls.
Participants with GD should have confirmed GD diagnosis, mutation confirmed for carriers and healthy controls confirmed to have no GBA1 mutation by gene sequencing.
You may not be if
Exclude participants who have any hematological malignancy or other uncontrolled comorbid conditions.
Exclude participants who are currently on therapy for their GD
Exclude participants who have any hematological malignancy or other uncontrolled comorbid conditions.
Clareo Health | Extracellular Vesicles as Potential Biomarkers and Therapeutic Target in Gaucher Disease
